For over four decades, the medical device industry has wrestled with fragmented data exchange and proprietary integrations. HL7’s Device Interoperability FHIR Accelerator initiative offers a vendor-neutral framework to finally achieve plug-and-play interoperability—unlocking scalable, AI-powered MedTech innovation and improving patient outcomes.
Key trends picking up momentum in the field of healthcare. How GenAI is revolutionizing clinical workflows. The rise of ambient technologies in patient care. IoMT devices and SaMD solutions to enable patient care. Interoperability and automation of data. Cybersecurity to ensure the safety of personal data.
Up until now, the lack of interoperable health-at-home devices has inhibited health technology integration into the home for use in wellness, prevention, managing chronic conditions, and clinical trials.
Continuous glucose monitoring (CGM) technology is rapidly expanding beyond Type 1 diabetes to reach a wider demographic, including Type 2 diabetics and wellness users. How manufacturers advancing CGM technology to address these diverse needs, focusing on ease of use, device reliability, and adherence strategies? By prioritizing these areas, manufacturers can empower a growing user base to manage their health more effectively and independently.
The integration of technology and connectivity into healthcare is not only improving patient outcomes but also reshaping the way care is delivered.
AI and real-time data enhance care efficiency and access. And with healthcare workers in short supply, the rapid advancements in AI, IoMT, and related innovation offer patient access freedom, enhanced care delivery, and better outcomes.
AI has the ability to revolutionize the medical landscape, but to enable this, Quality Engineering is critically important.
This blog explores the transformative potential of AI assistants in healthcare management and delves into the benefits for providers, medical assistants, and obviously, patients.
CitiusTech Senior VP and Market Head, Healthcare Providers, John Squeo, shares five game-changing shifts that will redefine the future of US healthcare and unlock a more streamlined, accessible and patient-centric system.
The EU Data Act will be applicable from September 12, 2025. Given the consequent steps that will be required to comply with the EU Data Act, medical and health devices’ companies would do well to already commence assessing what they will need to do to comply with it.
